Association between the MTHFR C677T polymorphism and risk of cancer: evidence from 446 case–control studies

Many molecular epidemiological studies have been performed to explore the association between MTHFR C677T polymorphism and cancer risk in diverse populations. However, the results were inconsistent. Hence, we performed a meta-analysis to investigate the association between cancer risk and MTHFR C677...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Tumor biology 2015-11, Vol.36 (11), p.8953-8972
Hauptverfasser: Xie, Shu-Zhe, Liu, Zhi-Zhong, Yu, Jun-hua, Liu, Li, Wang, Wei, Xie, Dao-Lin, Qin, Jiang-Bo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 8972
container_issue 11
container_start_page 8953
container_title Tumor biology
container_volume 36
creator Xie, Shu-Zhe
Liu, Zhi-Zhong
Yu, Jun-hua
Liu, Li
Wang, Wei
Xie, Dao-Lin
Qin, Jiang-Bo
description Many molecular epidemiological studies have been performed to explore the association between MTHFR C677T polymorphism and cancer risk in diverse populations. However, the results were inconsistent. Hence, we performed a meta-analysis to investigate the association between cancer risk and MTHFR C677T (150,086 cases and 200,699 controls from 446 studies) polymorphism. Overall, significantly increased cancer risk was found when all eligible studies were pooled into the meta-analysis. In the further stratified and sensitivity analyses, significantly increased breast cancer risk was found in Asians and Indians, significantly decreased colon cancer risk was found, significantly decreased colorectal cancer risk was found in male population, significantly increased gastric cancer risk was found in Caucasians and Asians, significantly increased hepatocellular cancer risk was found in Asians, significantly decreased adult acute lymphoblastic leukemia (AALL) risk was found in Caucasians, significantly decreased childhood acute lymphoblastic leukemia (CALL) risk was found in Asians, and significantly increased multiple myeloma and NHL risk was found in Caucasians. In summary, this meta-analysis suggests that MTHFR C677T polymorphism is associated with increased breast cancer, gastric cancer, and hepatocellular cancer risk in Asians, is associated with increased gastric cancer, multiple myeloma, and NHL risk in Caucasians, is associated with decreased AALL risk in Caucasians, is associated with decreased CALL risk in Asians, is associated with increased breast cancer risk in Asians, is associated with decreased colon cancer risk, and is associated with decreased colorectal cancer risk in male population. Moreover, this meta-analysis also points out the importance of new studies, such as Asians of HNC, Asians of lung cancer, and Indians of breast cancer, because they had high heterogeneity in this meta-analysis ( I 2  > 75 %).
doi_str_mv 10.1007/s13277-015-3648-z
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1747328665</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3897220271</sourcerecordid><originalsourceid>FETCH-LOGICAL-c508t-f6b78751a8f3b35cb108a4a19ac0ed13a65732c7f634cd4bdc4095fcd9d56eed3</originalsourceid><addsrcrecordid>eNp1kcFO3DAQhq2qqFDaB-BSWeqFS8COHdvpDa1KQQIhVduz5diTEprEW09CtZx4B96QJ8GrBVRV6ml-ab75ZzQ_IQecHXHG9DFyUWpdMF4VQklT3L0he1yWomDCsLdZM84KWRqxS94j3rAM1rV6R3ZLxQxXvN4jwwli9J2bujjSBqY_ACOdroFeLs9Ov9OF0npJV7FfDzGtrjscqBsDTR3-orGl3o0e0hcKt12ALGmb4kClVLmD8Hj_4OM4pdhTnObQAX4gO63rET4-133y4_TrcnFWXFx9O1-cXBS-YmYqWtVooyvuTCsaUfmGM-Ok47XzDAIXTlValF63SkgfZBO8ZHXV-lCHSgEEsU8Ot76rFH_PgJMdOvTQ926EOKPlWmYDo1SV0c__oDdxTmO-bkPVikmuVab4lvIpIiZo7Sp1g0try5ndZGG3Wdj8YrvJwt7lmU_PznMzQHideHl-BsotgLk1_oT01-r_uj4BxLqVPg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1749604176</pqid></control><display><type>article</type><title>Association between the MTHFR C677T polymorphism and risk of cancer: evidence from 446 case–control studies</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Xie, Shu-Zhe ; Liu, Zhi-Zhong ; Yu, Jun-hua ; Liu, Li ; Wang, Wei ; Xie, Dao-Lin ; Qin, Jiang-Bo</creator><creatorcontrib>Xie, Shu-Zhe ; Liu, Zhi-Zhong ; Yu, Jun-hua ; Liu, Li ; Wang, Wei ; Xie, Dao-Lin ; Qin, Jiang-Bo</creatorcontrib><description>Many molecular epidemiological studies have been performed to explore the association between MTHFR C677T polymorphism and cancer risk in diverse populations. However, the results were inconsistent. Hence, we performed a meta-analysis to investigate the association between cancer risk and MTHFR C677T (150,086 cases and 200,699 controls from 446 studies) polymorphism. Overall, significantly increased cancer risk was found when all eligible studies were pooled into the meta-analysis. In the further stratified and sensitivity analyses, significantly increased breast cancer risk was found in Asians and Indians, significantly decreased colon cancer risk was found, significantly decreased colorectal cancer risk was found in male population, significantly increased gastric cancer risk was found in Caucasians and Asians, significantly increased hepatocellular cancer risk was found in Asians, significantly decreased adult acute lymphoblastic leukemia (AALL) risk was found in Caucasians, significantly decreased childhood acute lymphoblastic leukemia (CALL) risk was found in Asians, and significantly increased multiple myeloma and NHL risk was found in Caucasians. In summary, this meta-analysis suggests that MTHFR C677T polymorphism is associated with increased breast cancer, gastric cancer, and hepatocellular cancer risk in Asians, is associated with increased gastric cancer, multiple myeloma, and NHL risk in Caucasians, is associated with decreased AALL risk in Caucasians, is associated with decreased CALL risk in Asians, is associated with increased breast cancer risk in Asians, is associated with decreased colon cancer risk, and is associated with decreased colorectal cancer risk in male population. Moreover, this meta-analysis also points out the importance of new studies, such as Asians of HNC, Asians of lung cancer, and Indians of breast cancer, because they had high heterogeneity in this meta-analysis ( I 2  &gt; 75 %).</description><identifier>ISSN: 1010-4283</identifier><identifier>EISSN: 1423-0380</identifier><identifier>DOI: 10.1007/s13277-015-3648-z</identifier><identifier>PMID: 26081619</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Alleles ; Biomedical and Life Sciences ; Biomedicine ; Cancer ; Cancer Research ; Genetic Association Studies ; Genetic Predisposition to Disease ; Genotype ; Humans ; Leukemia ; Meta-analysis ; Methylenetetrahydrofolate Reductase (NADPH2) - genetics ; Molecular biology ; Neoplasms - classification ; Neoplasms - genetics ; Neoplasms - pathology ; Polymorphism ; Polymorphism, Single Nucleotide ; Research Article ; Risk Factors</subject><ispartof>Tumor biology, 2015-11, Vol.36 (11), p.8953-8972</ispartof><rights>International Society of Oncology and BioMarkers (ISOBM) 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c508t-f6b78751a8f3b35cb108a4a19ac0ed13a65732c7f634cd4bdc4095fcd9d56eed3</citedby><cites>FETCH-LOGICAL-c508t-f6b78751a8f3b35cb108a4a19ac0ed13a65732c7f634cd4bdc4095fcd9d56eed3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s13277-015-3648-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s13277-015-3648-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,781,785,27925,27926,41489,42558,51320</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26081619$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xie, Shu-Zhe</creatorcontrib><creatorcontrib>Liu, Zhi-Zhong</creatorcontrib><creatorcontrib>Yu, Jun-hua</creatorcontrib><creatorcontrib>Liu, Li</creatorcontrib><creatorcontrib>Wang, Wei</creatorcontrib><creatorcontrib>Xie, Dao-Lin</creatorcontrib><creatorcontrib>Qin, Jiang-Bo</creatorcontrib><title>Association between the MTHFR C677T polymorphism and risk of cancer: evidence from 446 case–control studies</title><title>Tumor biology</title><addtitle>Tumor Biol</addtitle><addtitle>Tumour Biol</addtitle><description>Many molecular epidemiological studies have been performed to explore the association between MTHFR C677T polymorphism and cancer risk in diverse populations. However, the results were inconsistent. Hence, we performed a meta-analysis to investigate the association between cancer risk and MTHFR C677T (150,086 cases and 200,699 controls from 446 studies) polymorphism. Overall, significantly increased cancer risk was found when all eligible studies were pooled into the meta-analysis. In the further stratified and sensitivity analyses, significantly increased breast cancer risk was found in Asians and Indians, significantly decreased colon cancer risk was found, significantly decreased colorectal cancer risk was found in male population, significantly increased gastric cancer risk was found in Caucasians and Asians, significantly increased hepatocellular cancer risk was found in Asians, significantly decreased adult acute lymphoblastic leukemia (AALL) risk was found in Caucasians, significantly decreased childhood acute lymphoblastic leukemia (CALL) risk was found in Asians, and significantly increased multiple myeloma and NHL risk was found in Caucasians. In summary, this meta-analysis suggests that MTHFR C677T polymorphism is associated with increased breast cancer, gastric cancer, and hepatocellular cancer risk in Asians, is associated with increased gastric cancer, multiple myeloma, and NHL risk in Caucasians, is associated with decreased AALL risk in Caucasians, is associated with decreased CALL risk in Asians, is associated with increased breast cancer risk in Asians, is associated with decreased colon cancer risk, and is associated with decreased colorectal cancer risk in male population. Moreover, this meta-analysis also points out the importance of new studies, such as Asians of HNC, Asians of lung cancer, and Indians of breast cancer, because they had high heterogeneity in this meta-analysis ( I 2  &gt; 75 %).</description><subject>Alleles</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer</subject><subject>Cancer Research</subject><subject>Genetic Association Studies</subject><subject>Genetic Predisposition to Disease</subject><subject>Genotype</subject><subject>Humans</subject><subject>Leukemia</subject><subject>Meta-analysis</subject><subject>Methylenetetrahydrofolate Reductase (NADPH2) - genetics</subject><subject>Molecular biology</subject><subject>Neoplasms - classification</subject><subject>Neoplasms - genetics</subject><subject>Neoplasms - pathology</subject><subject>Polymorphism</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Research Article</subject><subject>Risk Factors</subject><issn>1010-4283</issn><issn>1423-0380</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kcFO3DAQhq2qqFDaB-BSWeqFS8COHdvpDa1KQQIhVduz5diTEprEW09CtZx4B96QJ8GrBVRV6ml-ab75ZzQ_IQecHXHG9DFyUWpdMF4VQklT3L0he1yWomDCsLdZM84KWRqxS94j3rAM1rV6R3ZLxQxXvN4jwwli9J2bujjSBqY_ACOdroFeLs9Ov9OF0npJV7FfDzGtrjscqBsDTR3-orGl3o0e0hcKt12ALGmb4kClVLmD8Hj_4OM4pdhTnObQAX4gO63rET4-133y4_TrcnFWXFx9O1-cXBS-YmYqWtVooyvuTCsaUfmGM-Ok47XzDAIXTlValF63SkgfZBO8ZHXV-lCHSgEEsU8Ot76rFH_PgJMdOvTQ926EOKPlWmYDo1SV0c__oDdxTmO-bkPVikmuVab4lvIpIiZo7Sp1g0try5ndZGG3Wdj8YrvJwt7lmU_PznMzQHideHl-BsotgLk1_oT01-r_uj4BxLqVPg</recordid><startdate>20151101</startdate><enddate>20151101</enddate><creator>Xie, Shu-Zhe</creator><creator>Liu, Zhi-Zhong</creator><creator>Yu, Jun-hua</creator><creator>Liu, Li</creator><creator>Wang, Wei</creator><creator>Xie, Dao-Lin</creator><creator>Qin, Jiang-Bo</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20151101</creationdate><title>Association between the MTHFR C677T polymorphism and risk of cancer: evidence from 446 case–control studies</title><author>Xie, Shu-Zhe ; Liu, Zhi-Zhong ; Yu, Jun-hua ; Liu, Li ; Wang, Wei ; Xie, Dao-Lin ; Qin, Jiang-Bo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c508t-f6b78751a8f3b35cb108a4a19ac0ed13a65732c7f634cd4bdc4095fcd9d56eed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Alleles</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer</topic><topic>Cancer Research</topic><topic>Genetic Association Studies</topic><topic>Genetic Predisposition to Disease</topic><topic>Genotype</topic><topic>Humans</topic><topic>Leukemia</topic><topic>Meta-analysis</topic><topic>Methylenetetrahydrofolate Reductase (NADPH2) - genetics</topic><topic>Molecular biology</topic><topic>Neoplasms - classification</topic><topic>Neoplasms - genetics</topic><topic>Neoplasms - pathology</topic><topic>Polymorphism</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Research Article</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xie, Shu-Zhe</creatorcontrib><creatorcontrib>Liu, Zhi-Zhong</creatorcontrib><creatorcontrib>Yu, Jun-hua</creatorcontrib><creatorcontrib>Liu, Li</creatorcontrib><creatorcontrib>Wang, Wei</creatorcontrib><creatorcontrib>Xie, Dao-Lin</creatorcontrib><creatorcontrib>Qin, Jiang-Bo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Tumor biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xie, Shu-Zhe</au><au>Liu, Zhi-Zhong</au><au>Yu, Jun-hua</au><au>Liu, Li</au><au>Wang, Wei</au><au>Xie, Dao-Lin</au><au>Qin, Jiang-Bo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association between the MTHFR C677T polymorphism and risk of cancer: evidence from 446 case–control studies</atitle><jtitle>Tumor biology</jtitle><stitle>Tumor Biol</stitle><addtitle>Tumour Biol</addtitle><date>2015-11-01</date><risdate>2015</risdate><volume>36</volume><issue>11</issue><spage>8953</spage><epage>8972</epage><pages>8953-8972</pages><issn>1010-4283</issn><eissn>1423-0380</eissn><abstract>Many molecular epidemiological studies have been performed to explore the association between MTHFR C677T polymorphism and cancer risk in diverse populations. However, the results were inconsistent. Hence, we performed a meta-analysis to investigate the association between cancer risk and MTHFR C677T (150,086 cases and 200,699 controls from 446 studies) polymorphism. Overall, significantly increased cancer risk was found when all eligible studies were pooled into the meta-analysis. In the further stratified and sensitivity analyses, significantly increased breast cancer risk was found in Asians and Indians, significantly decreased colon cancer risk was found, significantly decreased colorectal cancer risk was found in male population, significantly increased gastric cancer risk was found in Caucasians and Asians, significantly increased hepatocellular cancer risk was found in Asians, significantly decreased adult acute lymphoblastic leukemia (AALL) risk was found in Caucasians, significantly decreased childhood acute lymphoblastic leukemia (CALL) risk was found in Asians, and significantly increased multiple myeloma and NHL risk was found in Caucasians. In summary, this meta-analysis suggests that MTHFR C677T polymorphism is associated with increased breast cancer, gastric cancer, and hepatocellular cancer risk in Asians, is associated with increased gastric cancer, multiple myeloma, and NHL risk in Caucasians, is associated with decreased AALL risk in Caucasians, is associated with decreased CALL risk in Asians, is associated with increased breast cancer risk in Asians, is associated with decreased colon cancer risk, and is associated with decreased colorectal cancer risk in male population. Moreover, this meta-analysis also points out the importance of new studies, such as Asians of HNC, Asians of lung cancer, and Indians of breast cancer, because they had high heterogeneity in this meta-analysis ( I 2  &gt; 75 %).</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>26081619</pmid><doi>10.1007/s13277-015-3648-z</doi><tpages>20</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1010-4283
ispartof Tumor biology, 2015-11, Vol.36 (11), p.8953-8972
issn 1010-4283
1423-0380
language eng
recordid cdi_proquest_miscellaneous_1747328665
source MEDLINE; SpringerNature Journals
subjects Alleles
Biomedical and Life Sciences
Biomedicine
Cancer
Cancer Research
Genetic Association Studies
Genetic Predisposition to Disease
Genotype
Humans
Leukemia
Meta-analysis
Methylenetetrahydrofolate Reductase (NADPH2) - genetics
Molecular biology
Neoplasms - classification
Neoplasms - genetics
Neoplasms - pathology
Polymorphism
Polymorphism, Single Nucleotide
Research Article
Risk Factors
title Association between the MTHFR C677T polymorphism and risk of cancer: evidence from 446 case–control studies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T13%3A37%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20between%20the%20MTHFR%20C677T%20polymorphism%20and%20risk%20of%20cancer:%20evidence%20from%20446%20case%E2%80%93control%20studies&rft.jtitle=Tumor%20biology&rft.au=Xie,%20Shu-Zhe&rft.date=2015-11-01&rft.volume=36&rft.issue=11&rft.spage=8953&rft.epage=8972&rft.pages=8953-8972&rft.issn=1010-4283&rft.eissn=1423-0380&rft_id=info:doi/10.1007/s13277-015-3648-z&rft_dat=%3Cproquest_cross%3E3897220271%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1749604176&rft_id=info:pmid/26081619&rfr_iscdi=true